Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2013 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection.
Collinson F, Hutchinson M, Craven RA, Cairns DA, Zougman A, Wind TC, Gahir N, Messenger MP, Jackson S, Thompson D, Adusei C, Ledermann JA, Hall G, Jayson GC, Selby PJ, Banks RE. Collinson F, et al. Clin Cancer Res. 2013 Sep 15;19(18):5227-39. doi: 10.1158/1078-0432.CCR-13-0489. Epub 2013 Aug 9. Clin Cancer Res. 2013. PMID: 23935036 Free PMC article. Clinical Trial.
New therapeutic agents in ovarian cancer.
Collinson F, Jayson G. Collinson F, et al. Curr Opin Obstet Gynecol. 2009 Feb;21(1):44-53. doi: 10.1097/GCO.0b013e32831ffe71. Curr Opin Obstet Gynecol. 2009. PMID: 19125003 Review.
Development of antiangiogenic agents for ovarian cancer.
Collinson FJ, Hall GD, Perren TJ, Jayson GC. Collinson FJ, et al. Expert Rev Anticancer Ther. 2008 Jan;8(1):21-32. doi: 10.1586/14737140.8.1.21. Expert Rev Anticancer Ther. 2008. PMID: 18095880 Review.